Historically, surgery was rarely considered an option once bladder cancer had metastasized (spread beyond the bladder). However, emerging research suggests that for certain patients, surgical intervention can significantly extend survival and improve quality of life.
Rather than being a “one-size-fits-all” approach, surgical decisions for metastatic disease are highly individualized. They are typically determined by a multidisciplinary team of specialists who weigh the patient’s overall health, the location of the tumors, and how well they have responded to prior treatments like chemotherapy.
Primary Surgical Approaches
Depending on the extent of the disease, doctors may recommend one of the following procedures:
1. Cytoreductive Surgery
The goal of cytoreductive surgery is to reduce the “tumor burden”—the total amount of cancer in the body.
– How it works: This may involve removing the primary tumor in the bladder via TURBT (a minimally invasive procedure through the urethra) or removing tumors in other areas of the body.
– Why it matters: Reducing the tumor mass can make subsequent treatments, such as chemotherapy, more effective. It also allows doctors to examine the tissue directly to better assess treatment progress.
– Risks: Beyond standard surgical risks (infection, bleeding), repeated bladder procedures can cause scarring, which may lead to urinary incontinence or the need to urinate more frequently.
2. Radical Cystectomy and Urinary Diversion
If the cancer is large or has spread extensively within the bladder, a radical cystectomy may be necessary.
– The Procedure: This involves the complete removal of the bladder and nearby lymph nodes. In men, this often includes the prostate; in women, it may involve the uterus, ovaries, and parts of the vagina.
– Urinary Diversion: Because the bladder is removed, surgeons must create a new way for urine to exit the body. Options include:
– Nephrostomy: A tube draining urine from the kidney through the back.
– Urostomy: Using a piece of the intestine to create a passage for urine to drain into an external bag.
– Bladder Substitute: Using intestinal tissue to create a new “reservoir” that allows the patient to hold urine.
– Considerations: While this can remove the primary source of cancer, it carries risks of sexual dysfunction and requires significant lifestyle adjustments.
3. Metastasectomy
A metastasectomy targets tumors that have spread to distant organs, such as the lungs or lymph nodes.
– Targeted Benefit: This is most effective for patients with oligometastatic disease (a limited number of tumors). In rare cases, such as a single tumor in the lung, complete removal may even lead to long-term, disease-free survival.
– Symptom Relief: Beyond treating the cancer, removing a tumor from the lungs can alleviate chronic coughing and pain.
Palliative Surgery: Prioritizing Quality of Life
Not all surgery aims for a cure. Palliative surgery focuses on relieving symptoms and preventing further complications. This might include:
– Reducing pain caused by large tumors.
– Preventing fistulas (abnormal openings between organs, such as the bladder and vagina).
Note: Palliative procedures, such as urinary diversion, can also prevent kidney damage by clearing blockages and urine backups.
Making an Informed Decision
Deciding on surgery for metastatic cancer is a complex process. Patients are encouraged to consult with a coordinated team—including surgeons, radiation oncologists, and medical oncologists—to evaluate their specific situation.
Key questions to discuss with your care team:
– How does my response to chemotherapy affect my surgical eligibility?
– What are the specific risks to my sexual health or urinary function?
– Am I eligible for clinical trials? (Research is ongoing regarding the optimal timing for surgery and new immunotherapy combinations).
Conclusion
While metastatic bladder cancer presents significant challenges, surgery has emerged as a vital tool for controlling symptoms, enhancing the efficacy of other treatments, and potentially extending life. The right path depends on a highly personalized assessment of the cancer’s spread and the patient’s unique health profile.
